1	Regulation	regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	double-stranded	double-stranded	_	_	_	_	_	_	_
7	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
8	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	Alteration	Alteration	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	gene	gene	_	_	_	_	_	_	_
4	transcription	transcription	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	inhibition	inhibition	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	specific	specific	_	_	_	_	_	_	_
9	transcriptional	transcriptional	_	_	_	_	_	_	_
10	regulatory	regulatory	_	_	_	_	_	_	_
11	proteins	protein	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	necessary	necessary	_	_	_	_	_	_	_
14	for	for	_	_	_	_	_	_	_
15	determining	determine	_	_	_	_	_	_	_
16	how	how	_	_	_	_	_	_	_
17	these	these	_	_	_	_	_	_	_
18	factors	factor	_	_	_	_	_	_	_
19	participate	participate	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	cellular	cellular	_	_	_	_	_	_	_
22	differentiation	differentiation	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	functions	function	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	proteins	protein	_	_	_	_	_	_	_
6	can	can	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	antagonized	antagonize	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	several	several	_	_	_	_	_	_	_
11	methods	method	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	each	each	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	specific	specific	_	_	_	_	_	_	_
16	limitations	limitation	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	sequence-specific	sequence-specific	_	_	_	_	_	_	_
4	DNA-binding	dna-binding	_	_	_	_	_	_	_
5	proteins	protein	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	achieved	achieve	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	double-stranded	double-stranded	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	ds	d	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
14	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	contained	contain	_	_	_	_	_	_	_
17	octamer	octamer	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	kappa	kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	consensus	consensus	_	_	_	_	_	_	_
22	sequences	sequence	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
3	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
4	specifically	specifically	_	_	_	_	_	_	_
5	bound	bind	_	_	_	_	_	_	_
6	either	either	_	_	_	_	_	_	_
7	octamer	octamer	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	or	or	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
15	B.	B.	_	_	_	_	_	_	_
16	The	the	_	_	_	_	_	_	_
17	modified	modified	_	_	_	_	_	_	_
18	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
19	accumulated	accumulate	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	more	more	_	_	_	_	_	_	_
23	effectively	effectively	_	_	_	_	_	_	_
24	than	than	_	_	_	_	_	_	_
25	standard	standard	_	_	_	_	_	_	_
26	ds	d	_	_	_	_	_	_	_
27	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	modulated	modulate	_	_	_	_	_	_	_
30	gene	gene	_	_	_	_	_	_	_
31	expression	expression	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	specific	specific	_	_	_	_	_	_	_
35	manner	manner	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Octamer-dependent	octamer-dependent	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	reporter	reporter	_	_	_	_	_	_	_
6	plasmid	plasmid	_	_	_	_	_	_	_
7	or	or	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B-dependent	b-dependent	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
15	virus	virus	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	HIV	HIV	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	enhancer	enhancer	_	_	_	_	_	_	_
20	was	be	_	_	_	_	_	_	_
21	inhibited	inhibit	_	_	_	_	_	_	_
22	when	when	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	appropriate	appropriate	_	_	_	_	_	_	_
25	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
26	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
27	was	be	_	_	_	_	_	_	_
28	added	add	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	transiently	transiently	_	_	_	_	_	_	_
32	transfected	transfecte	_	_	_	_	_	_	_
33	B	B	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	line	line	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Addition	addition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
4	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	contained	contain	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	octamer	octamer	_	_	_	_	_	_	_
9	consensus	consensus	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	Jurkat	Jurkat	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	leukemia	leukemia	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	inhibited	inhibit	_	_	_	_	_	_	_
16	interleukin-2	interleukin-2	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	secretion	secretion	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	degree	degree	_	_	_	_	_	_	_
24	similar	similar	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	observed	observe	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	a	a	_	_	_	_	_	_	_
30	mutated	mutate	_	_	_	_	_	_	_
31	octamer	octamer	_	_	_	_	_	_	_
32	site	site	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	the	the	_	_	_	_	_	_	_
35	IL-2	il-2	_	_	_	_	_	_	_
36	enhancer	enhancer	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	ds	d	_	_	_	_	_	_	_
3	phosphorothioate	phosphorothioate	_	_	_	_	_	_	_
4	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
5	probably	probably	_	_	_	_	_	_	_
6	compete	compete	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	binding	binding	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	specific	specific	_	_	_	_	_	_	_
11	transcription	transcription	_	_	_	_	_	_	_
12	factors	factor	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	provide	provide	_	_	_	_	_	_	_
16	anti-viral	anti-viral	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	other	other	_	_	_	_	_	_	_
22	therapeutic	therapeutic	_	_	_	_	_	_	_
23	effects	effect	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

